Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Letter From the CMO in England to Reduce Antibiotic Prescribing in General Practice: A Randomized Controlled Trial Comparing Monitoring and Feedback (With and Without Graphs), and Social Norms Feedback (Without and Without a Specific Case Study of Patient Harm)

NCT04051281 is registered in ClinicalTrials.gov with Public Health England as lead sponsor.

NCT NCT04051281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04051281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Letter From the CMO in England to Reduce Antibiotic Prescribing in General Practice: A Randomized Controlled Trial Comparing Monitoring and Feedback (With and Without Graphs), and Social Norms Feedback (Without and Without a Specific Case Study of Patient Harm)
Lead sponsor
Public Health England
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2019
Completion date
August 30, 2020
Enrollment
2,963 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prescribing, off-label